Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism IRAK4 inhibitors(Interleukin-1 receptor-associated kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Odyssey Therapeutics, Inc.Startup |
Active Organization Odyssey Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Preclinical | US | Odyssey Therapeutics, Inc.Startup | 01 Dec 2024 |
Hidradenitis Suppurativa | Preclinical | US | Odyssey Therapeutics, Inc.Startup | 01 Dec 2024 |
Osteoarthritis | Preclinical | US | Odyssey Therapeutics, Inc.Startup | 01 Dec 2024 |